echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > A summary of the top guidelines for the first half of the infectious disease department, click to glance!

    A summary of the top guidelines for the first half of the infectious disease department, click to glance!

    • Last Update: 2022-09-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article summarizes the recently released consensus of relevant guidelines in the field of infection at home and abroad, for everyone to check and download!



    Sepsis is currently defined as a dysfunction of a life-threatening organ caused by a dysfunctional host response to infection



    Download link:

    https://guide.


    Recommended Reading:

    Empirical antimicrobial therapy for patients with sepsis, SWAB guideline recommendations at a glance!



    Pseudomonas aeruginosa (PA) is one of the most common pathogenic bacteria for refractory lower respiratory tract infections, making treatment more difficult



    Download link:

    https://guide.


    Recommended Reading:

    Antibacterial drugs with anti-Pseudomonas aeruginosa activity, common dosages and adverse reactions see here!



    In order to further guide all localities to do a good job in the prevention and control of the monkeypox epidemic, standardize the epidemiological investigation of monkeypox, the determination and management of contacts, laboratory testing, etc.



    Download link:

    https://guide.


    Recommended Reading:

    National Health Commission Releases Guidelines for the Diagnosis and Treatment of MonkeyPox (2022 Edition)



    2022 WHO Guidelines: Diagnosis, prevention and management of cryptococcosis in adults, adolescents and children living with HIV

    One
    of the most common opportunistic infections in people with advanced HIV infection with cryptococcosis.

    In June 2022, the World Health Organization (WHO) published guidelines for the diagnosis, prevention and management of cryptococcosis in adults, adolescents and children living with HIV, which provide guidance
    on the diagnosis, prevention and management of cryptococcosis in adults, adolescents and children with HIV infection.

    Download link:

    https://guide.
    medlive.
    cn/guideline/26200

    Recommended Reading:

    2022 WHO Guidelines: Diagnosis, prevention and management of cryptococcosis in adults, adolescents, and children living with HIV


    2022 Japan Guide: Management of Clostridium difficile infection

    Clostridium difficile (CD) is the most common anaerobic pathogen causing hospital- or healthcare-related infections
    .

    The clinical manifestations of Clostridium difficile infection (CDI) are predominantly diarrhea and pseudomembranous colitis, and patient outcomes range from asymptomatic bacterial colonization to severe diarrhea, or further progression to toxic megacolon, intestinal perforation, septic shock, and even death
    .

    The Japanese CDI Management Guidelines propose a clear CDI diagnosis and treatment process
    .

    Download link:

    https://guide.
    medlive.
    cn/guideline/26051

    Recommended Reading:

    For the diagnosis and treatment of Clostridium infection, see the latest guidelines in Japan!


    2022 Expert Advice: Prevention and Management of Candida Auris transmission

    Candida auris is a novel multidrug-resistant fungus that causes invasive infections
    primarily in immunocompromised hospitalized patients.

    Since it was first reported in 2009, the bacterium has swept across 44 countries on 6 continents, making it a serious threat
    to health care.

    Recently, experts from Germany published the "2022 Expert Advice: Prevention and Management of Candida Auris Transmission", which provides a series of guidance and suggestions
    for the prevention and management of Candida auris transmission.

    Download link:

    https://guide.
    medlive.
    cn/guideline/26257

    Recommended Reading:

    From the latest expert recommendations to see the identification and clinical treatment of Candida auris infection


    2022 IDSA Guidelines: Treatment of Antimicrobial Resistant Gram-Negative Bacterial Infections (V2.
    0)

    Carbapenem-resistant Acinetobacter baumannii (CRAB) infection poses a major challenge to medical institutions, and the main reasons why CRAB infection is difficult to treat are: 1) CRAB can often be regained from respiratory specimens and wounds; 2) Once Acinetobacter baumann exhibits carbapenem resistance, resistance usually develops against most other antibiotics that are expected to be active against wild-type Acinetobacter baumannii, resulting in few treatment options remaining; 3) There is no explicit standard antibiotic regimen for CRAB infection to assess the effectiveness
    of various treatment options.

    The American Society of Infectious Diseases (IDSA) recently published guidelines for the treatment of antimicrobial-resistant Gram-negative bacterial infections, version 2.
    0, which provide guidance on the treatment of CRAB infections
    .

    Download link:

    https://guide.
    medlive.
    cn/guideline/26050

    Recommended Reading:

    Treatment of carbapenem-resistant Acinetobacter baumann infections, see IDSA guidelines recommended!


    Expert consensus on the application of vaccines for common infectious diseases in the elderly in the community

    Infectious disease (infectious disease) is a general term for diseases caused by pathogenic microorganisms, which have a high incidence and high case fatality rate in the elderly population, which seriously affect the quality of life of the elderly and cause a heavy economic burden, and have become one
    of the major public health problems in the world.

    Vaccination is a measure that specifically protects susceptible populations, improves the level of specific immunity in vaccinated populations, and reduces the risk
    of infectious diseases and related complications.

    Vaccination can also slow the progression of chronic diseases in older adults by preventing infections, reducing the risk
    of adverse outcomes from complications of chronic diseases.

    Regarding the vaccination of the elderly in the community against recombinant herpes zoster vaccine (RZV), let's look at the latest expert consensus recommendations
    .

    Download link:

    https://guide.
    medlive.
    cn/guideline/25027

    Recommended Reading:

    Community elderly vaccinated against shingles, see expert consensus recommendations!


    Expert consensus on the clinical application of laboratory diagnostic methods for invasive mycosis

    The prevalence and mortality rate of invasive fungal diseases continue to rise, seriously threatening the health of patients, and early and accurate diagnosis is the key
    to improving patient outcomes.

    The Expert Consensus on the Clinical Application of Laboratory Diagnostic Methods for Invasive Mycoses introduces and makes suggestions on the application population, test requirements, interpretation of results and clinical significance of invasive mycoses diagnostic methods
    .

    Download link:

    https://guide.
    medlive.
    cn/guideline/25182

    Recommended Reading:

    Clinical application of invasive mycopathy microbiological examination and histopathological examination, expert consensus recommends see here!


    2022 IATDMCT Position Statement: Best Practices for Drug Monitoring for Vancomycin Therapy

    When treated clinically with vancomycin, individualized dosing methods based on therapeutic drug monitoring (TDM) data can improve patient outcomes
    compared with fixed or empiric methods of administration.

    A growing body of evidence supports the use of an area under the curve (AUC24) to guide TDM's approach to guiding dosing decisions
    in patients receiving vancomycin therapy in excess of 48.

    Recently, the International Society for Therapeutic Drug Monitoring and Clinical Toxicity (IATDMCT) published a Best Practice Statement for Vancomycin Therapeutic Drug Monitoring, highlighting the pre-, post-analysis, and analysis processes of vancomycin TDM and its effects on
    AUC valley concentrations.

    Download link:

    https://guide.
    medlive.
    cn/guideline/24933

    Recommended Reading:

    Best Practices for Drug Monitoring for Vancomycin Therapy: IATDMCT Recommendations at a Glance!


    2022 ESCMID Quick Guide: Assessment and management of long-term symptoms of COVID-19

    With more than 300 million people recovering from COVID-19 worldwide, the public health implications of long-term COVID will be far-reaching
    .

    Long-term symptoms of COVID-19 are an umbrella term that refers to the signs and symptoms that persist after SARS-CoV-2 infection
    .

    The most common symptoms include fatigue, breathing difficulties, cognitive impairment, and symptoms of various pains (chest pain, headache, muscle pain
    ).

    In February 2022, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published quick guidelines
    for the assessment and management of long-term symptoms of COVID-19.

    Download link:

    https://guide.
    medlive.
    cn/guideline/25163

    Recommended Reading:

    Assessment of long-term symptoms of COVID-19, ESCMID guidelines recommend a list!


    Expert consensus on the rational use of glucocorticoids in the treatment of tuberculosis

    Glucocorticoids (GCs) have anti-inflammatory, anti-allergic, anti-bacterial endotoxins and immunosuppressive pharmacological effects, which can alleviate the immune damage
    caused by the body's allergic reaction to Mycobacterium tuberculosis.

    However, GCs can lead to adverse reactions such as dysbacteriosis, peptic ulcer, and osteoporosis while rapidly controlling the disease
    .

    There is an irrational clinical
    use of GCs to assist in the treatment of tuberculosis.

    The Expert Consensus on the Rational Application of Glucocorticoids in tuberculosis treatment mainly puts forward 22 recommendations for the adjuvant treatment of tuberculosis by GCs, in order to better guide the standardized application
    of GCs.

    Download link:

    https://guide.
    medlive.
    cn/guideline/24870

    Recommended Reading:

    Glucocorticoids adjuvant therapy for tuberculosis, see the latest expert consensus!


    2022 JSC/JSTDM Clinical Practice Guidelines: Pharmacological Monitoring of Teicoplanin

    Ticoplanin is a glycopeptide antibiotic that has a good effect on methicillin-resistant infections caused by Staphylococcus aureus (MRSA) and has been widely used in the treatment
    of PEOPLEA-infected patients due to the low risk of adverse effects of this drug.

    Recently, the Japanese Chemotherapy Society (JSC) and the Japanese Society for Therapeutic Drug Monitoring (JSTDM) jointly published guidelines for the monitoring of levoplanin in order to better manage patients
    receiving levoplanin.

    Download link:

    https://guide.
    medlive.
    cn/guideline/24926

    Recommended Reading:

    Drug monitoring for the treatment of coronanin, a list of recommendations recommended by Japanese guidelines!


    Expert consensus on emergency diagnosis and treatment of acute respiratory viral infection in adults

    Acute respiratory tract infections are divided into upper respiratory tract infections and lower respiratory tract infections, and the pathogenic microorganisms that cause acute respiratory infections include viruses, bacteria, fungi, mycoplasma and chlamydia
    .

    The Emergency Medicine Branch of the Chinese Medical Association organized experts in emergency medicine and other related fields to formulate the "Expert Consensus on emergency treatment of acute respiratory viral infection in adults"
    based on evidence-based medical evidence and clinical real-world results.

    Download link:

    https://guide.
    medlive.
    cn/guideline/24794

    Recommended Reading:

    Adult acute respiratory viral infection, expert consensus recommendation at a glance!

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.